HEALTH | Justice Has a Name: Henrietta Lacks’ Family Wins Again

The estate of a Black woman whose cells were stolen without consent has secured another landmark settlement — this time against pharmaceutical giant Novartis 

They took her cells without asking. They built empires without acknowledging her. For decades, the name Henrietta Lacks was known in laboratories across the world while her family struggled with chronic illness and no health insurance. Now, justice — long overdue and hard won — has arrived again.

The estate of Henrietta Lacks has reached a settlement with Novartis, one of the world’s largest pharmaceutical companies, resolving a lawsuit that accused the Swiss-based giant of unjustly profiting from a cell line cultivated from tissue taken from a poor Black tobacco farmer from Virginia — tissue extracted without her knowledge, without her consent, and without a single cent ever reaching her family.

The settlement, finalized in federal court in Maryland, marks another seismic legal victory for the Lacks estate and its legal team. Financial terms remain confidential, but the significance of holding a multi-billion-dollar pharmaceutical corporation accountable before a federal court cannot be overstated. This is not merely about money. This is about the price of a racist medical system that for generations treated Black bodies as resources to be mined rather than human beings to be respected.

The Immortal Wrong

The facts of this case read like something from a darker chapter of history — because they are. In 1951, doctors at Johns Hopkins Hospital removed cells from Henrietta Lacks’ cervical tumor during a biopsy. She was 31 years old, a mother of five, fighting for her life. She never knew what was taken. She died that same year and was buried in an unmarked grave.

But her cells did not die. Against every known scientific expectation at the time, they survived, multiplied, and thrived in laboratories. The HeLa cell line — named for Henrietta Lacks — became the cornerstone of modern medicine. These “immortal” cells helped develop the polio vaccine. They unlocked genetic mapping. They accelerated the development of COVID-19 vaccines. The scientific debt owed to Henrietta Lacks is, by any honest accounting, incalculable.

The financial rewards reaped by corporations from that debt? Equally immeasurable — and none of it reached her family.

A Pattern of Corporate Exploitation Confronted

This settlement with Novartis is the second major resolution in a series of lawsuits filed by the Lacks estate. In 2023, biotechnology company Thermo Fisher Scientific settled after attorneys argued the company continued to commercialize the HeLa cell line long after its origins became widely known — and profited handsomely while doing so.

Active litigation continues against Ultragenyx Pharmaceutical and Viatris, and attorneys for the family have signaled that additional complaints may follow. The message to the pharmaceutical industry is becoming impossible to ignore: the era of profiting with impunity from Henrietta Lacks’ stolen legacy is over.

More Than a Settlement

What the Lacks family has accomplished through these legal battles extends far beyond the courtroom. They have forced a reckoning with the foundational ethics of biomedical research — how cells are obtained, who consents, who benefits, and who is left behind. They have compelled some of the world’s most powerful corporations to answer for actions rooted in a system that viewed Black patients as subjects rather than citizens.

Henrietta Lacks spent her final months at Johns Hopkins unaware that she was contributing to medical history. She died without recognition, without compensation, without so much as a proper headstone. Her family carried that silence for generations.

They are silent no longer.

And the world’s pharmaceutical giants — one courtroom at a time — are being made to listen.

The Lacks estate continues active litigation against additional pharmaceutical companies. Further lawsuits are anticipated.

© WiredJa | wiredja.com